# A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas

> **NCT06882746** · PHASE1 · RECRUITING · sponsor: **Boehringer Ingelheim** · enrollment: 135 (estimated)

## Conditions studied

- Colorectal Carcinoma
- Gastric Carcinoma
- Pancreatic Ductal Adenocarcinoma

## Interventions

- **DRUG:** BI 765049

## Key facts

- **NCT ID:** NCT06882746
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-28
- **Primary completion:** 2026-12-11
- **Final completion:** 2027-05-12
- **Target enrollment:** 135 (ESTIMATED)
- **Last updated:** 2026-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06882746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06882746, "A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06882746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*